Primary aldosteronism: state-of-the-art review

A Vaidya, GL Hundemer, K Nanba… - American Journal of …, 2022 - academic.oup.com
We are witnessing a revolution in our understanding of primary aldosteronism (PA). In the
past 2 decades, we have learned that PA is a highly prevalent syndrome that is largely …

Pathogenesis and treatment of primary aldosteronism

MC Zennaro, S Boulkroun… - Nature Reviews …, 2020 - nature.com
Early diagnosis and appropriate treatment of primary aldosteronism, the most frequent
cause of secondary hypertension, are crucial to prevent deleterious cardiovascular …

Neuronal Cav3 channelopathies: recent progress and perspectives

P Lory, S Nicole, A Monteil - Pflügers Archiv-European Journal of …, 2020 - Springer
T-type, low-voltage activated, calcium channels, now designated Cav3 channels, are
involved in a wide variety of physiological functions, especially in nervous systems. Their …

The adrenal cortex and its disorders

WL Miller, CE Flück, DT Breault, BJ Feldman - Sperling Pediatric …, 2021 - Elsevier
The adrenal cortex produces dozens of steroids having varying degrees of glucocorticoid,
mineralocorticoid, and androgenic activity. Cortisol, the principal glucocorticoid, and …

New advances in endocrine hypertension: from genes to biomarkers

FL Fernandes-Rosa, S Boulkroun, B Fedlaoui… - Kidney International, 2023 - Elsevier
Hypertension (HT) is a major cardiovascular risk factor that affects 10% to 40% of the
general population in an age-dependent manner. Detection of secondary forms of HT is …

Prevalence, diagnosis and outcomes of treatment for primary aldosteronism

Y Yang, M Reincke, TA Williams - Best Practice & Research Clinical …, 2020 - Elsevier
Primary aldosteronism (PA) is the most common potentially curable form of hypertension.
The overproduction of aldosterone leads to an increased risk of cardiovascular and …

Primary aldosteronism: KCNJ5 mutations and adrenocortical cell growth

Y Yang, CE Gomez-Sanchez, D Jaquin… - …, 2019 - Am Heart Assoc
Aldosterone-producing adenomas with somatic mutations in the KCNJ5 G-protein–coupled
inwardly rectifying potassium channel are a cause of primary aldosteronism. These …

[HTML][HTML] Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess

KR Beck, A Odermatt - Molecular and Cellular Endocrinology, 2021 - Elsevier
The syndromes of mineralocorticoid excess describe a heterogeneous group of clinical
manifestations leading to endocrine hypertension, typically either through direct activation of …

Pathophysiology of bilateral hyperaldosteronism

K Nanba, WE Rainey - Current Opinion in Endocrinology …, 2022 - journals.lww.com
Research over the past 10 years has significantly improved our understanding of the
molecular pathogenesis of bilateral PA. Based on the improved understanding of BHA …

Diverse responses of autoantibodies to the angiotensin II type 1 receptor in primary aldosteronism

TA Williams, D Jaquin, J Burrello, A Philippe… - …, 2019 - Am Heart Assoc
Primary aldosteronism is a common form of endocrine hypertension mainly caused by a
unilateral aldosterone-producing adenoma (APA) or bilateral adrenal hyperplasia (BAH) …